drugset / Trial / NCT00864162
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions
RandomizedCrossoverOpen-label
Summary
To compare the rate of absorption and oral bioavailability of a test formulation of Ramipril10 mg Capsules manufactured by Purepac Pharmaceutical Company to an equivalent oral dose of the commercially available reference product Atlace® manufactured by Monarch Pharmaceuticals Inc. administrated to healthy subjects after a 10-hour overnight fast followed by a high-calorie, high-fat breakfast meal.
Timeline
- Start
- 2004-09
- Primary completion
- 2004-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramipril | Small molecule | 10 mg | Oral |
Indications
No indication recorded.